South Wales, Sept. 17 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "K2 THERAPEUTICS" on Aug. 19. The details about the trademark application no. UK00004251358 published in the journal no. 2025/037 (Sept. 12).
With Morgan, Lewis & Bockius UK LLP as representative, K2 Therapeutics Pte. Ltd. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical products for the prevention and treatment of disease, namely, cancer, autoimmune diseases and immunological diseases; therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases and immunological diseases; pharmaceuticals being medicines comprised of small molecules, cell therapies, nucleic acids and biologics for treatment of cancer, autoimmune diseases and immunological diseases; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases and immunological diseases, and for use in the fields of oncology, auto-immunity and immunology.
Class 42 : Pharmaceutical research and development; scientific research and development; medical research; development in the field of medical products and preparations; medical research, development, manufacturing and commercialization services in the fields of drug discovery, oncology, auto-immunity and immunology; development of manufacturing methods for others for pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases and immunological diseases, and for use in the fields of oncology, auto-immunity and immunology.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004251358
Disclaimer: Curated by HT Syndication.
